Model
Edge
Revance Therapeutics Inc.
0001848717
Filing Type
4
Filing Date
5/5/2022
Updated
5/6/22, 12:19 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership